Inventor · disambiguated record
David Richard
Also filed as: RICHARD DAVID · RICHARD DAVID J · RICHARD DAVID J J · RICHARD DAVID JAMES
32 granted patents·10 pending applications·140 citations·filing 2008–2024
97Inventor score
Files withFORMA THERAPEUTICS INC14NOVO NORDISK HEALTHCARE AG6EUTROPICS PHARMACEUTICALS INC5WYETH LLC5VALO HEALTH INC2
Top patents by PatentIndex Score
42 records- 0197US11980611B2Treating sickle cell disease with a pyruvate kinase R activating compoundNOVO NORDISK HEALTHCARE AG·Filed 2022·Granted May 14, 2024·3 cites·4 claims
- 0297US11844787B2Activating pyruvate kinase RNOVO NORDISK HEALTHCARE AG·Filed 2021·Granted Dec 19, 2023·5 cites·4 claims
- 0397US11649242B2Pyrrolopyrrole compositions as pyruvate kinase (PKR) activatorsFORMA THERAPEUTICS INC·Filed 2021·Granted May 16, 2023·5 cites·4 claims
- 0497US11071725B2Activating pyruvate kinase RFORMA THERAPEUTICS INC·Filed 2020·Granted Jul 27, 2021·8 cites·21 claims
- 0597US10675274B2Activating pyruvate kinase RFORMA THERAPEUTICS INC·Filed 2019·Granted Jun 9, 2020·12 cites·13 claims
- 0696US11014927B2Pyrrolopyrrole compositions as pyruvate kinase (PKR) activatorsFORMA THERAPEUTICS INC·Filed 2018·Granted May 25, 2021·6 cites·3 claims
- 0792US8039469B2Triazine compounds as PI3 kinase and mTOR inhibitorsWYETH LLC·Filed 2009·Granted Oct 18, 2011·15 cites·17 claims
- 0891US11001588B2Activating pyruvate kinase R and mutants thereofFORMA THERAPEUTICS INC·Filed 2019·Granted May 11, 2021·3 cites·15 claims
- 0991US10022381B2Triazine compounds as PI3 kinase and mTOR inhibitorsWYETH LLC·Filed 2015·Granted Jul 17, 2018·5 cites·6 claims
- 1091US8748421B2Triazine compounds as P13 kinase and MTOR inhibitorsWYETH LLC·Filed 2013·Granted Jun 10, 2014·11 cites·9 claims
- 1190US11814386B2Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitorsFORMA THERAPEUTICS INC·Filed 2022·Granted Nov 14, 2023·1 cites·20 claims
- 1290US2024391922A1Pyrrolopyrrole compositions as pyruvate kinase (pkr) activatorsNovo Nordisk Heathcare AG·Filed 2024·Application pending·0 cites
- 1389US8859542B2Triazine compounds as PI3 kinase and mTOR inhibitorsWYETH LLC·Filed 2014·Granted Oct 14, 2014·9 cites·12 claims
- 1489US8575159B2Triazine compounds as PI3 kinase and mTOR inhibitorsPFIZER·Filed 2012·Granted Nov 5, 2013·9 cites·21 claims
- 1589US8217036B2Triazine compounds as PI3 kinase and mTOR inhibitorsVENKATESAN ARANAPAKAM MUDUMBAI·Filed 2011·Granted Jul 10, 2012·12 cites·10 claims
- 1688US12071440B2Pyrrolopyrrole compositions as pyruvate kinase (PKR) activatorsNOVO NORDISK HEALTHCARE AG·Filed 2023·Granted Aug 27, 2024·0 cites·4 claims
- 1788US11247987B2Inhibiting ubiquitin specific peptidase 30FORMA THERAPEUTICS INC·Filed 2018·Granted Feb 15, 2022·3 cites·24 claims
- 1885US9174963B2Triazine compounds as PI3 kinase and MTOR inhibitorsWYETH LLC·Filed 2014·Granted Nov 3, 2015·5 cites·2 claims
- 1984US12128035B2Activating pyruvate kinase RNOVO NORDISK HEALTHCARE AG·Filed 2022·Granted Oct 29, 2024·1 cites·21 claims
- 2084US11535618B2Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitorsFORMA THERAPEUTICS INC·Filed 2019·Granted Dec 27, 2022·2 cites·21 claims
- 2184US8445486B2Triazine compounds as PI3 kinase and mTOR inhibitorsVENKATESAN ARANAPAKAM MUDUMBAI·Filed 2012·Granted May 21, 2013·5 cites·10 claims
- 2283US10889592B2Thienopyrazine carboxamides as ubiquitin-specific protease inhibitorsVALO EARLY DISCOVERY INC·Filed 2017·Granted Jan 12, 2021·2 cites·28 claims
- 2383US9051305B2Compositions and methods useful for treating diseasesCARDONE MICHAEL H·Filed 2012·Granted Jun 9, 2015·3 cites·23 claims
- 2483US8129371B2Thienopyrimidine and pyrazolopyrimidine compounds and their use as mTOR kinase and PI3 kinase inhibitorsZASK ARIE·Filed 2008·Granted Mar 6, 2012·11 cites·46 claims
- 2580US10913753B2Thienopyridine carboxamides as ubiquitin-specific protease inhibitorsFORMA THERAPEUTICS INC·Filed 2017·Granted Feb 9, 2021·2 cites·20 claims
- 2680US9345700B2Compositions and methods useful for treating diseasesEUTROPICS PHARMACEUTICALS INC·Filed 2015·Granted May 24, 2016·2 cites·19 claims
- 2778US2024132499A1Fused pyrrolines which act as ubiquitin-specific protease 30 (usp30) inhibitorsFORMA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2875US12053458B2Treating sickle cell disease with a pyruvate kinase R activating compoundNOVO NORDISK HEALTHCARE AG·Filed 2019·Granted Aug 6, 2024·0 cites·12 claims
- 2971US12122778B2Activating pyruvate kinase RNOVO NORDISK HEALTHCARE AG·Filed 2019·Granted Oct 22, 2024·0 cites·19 claims
- 3069US2021221816A1Activating pyruvate kinase r and mutants thereofFORMA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3168US10765673B2Methods and compositions useful for treating diseases involving Bcl-2 family proteins with quinoline derivativesEUTROPICS PHARMACEUTICALS INC·Filed 2018·Granted Sep 8, 2020·0 cites·10 claims
- 3268US2020405699A1Treating sickle cell disease with a pyruvate kinase r activating compoundFORMA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3367US2022185806A1Inhibiting ubiquitin specific peptidase 30FORMA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3464US2015150869A1Methods and compositions useful for treating diseases involving bcl-2 family proteins with quinoline derivativesEUTROPICS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3562US11325917B2Thienopyrazine carboxamides as ubiquitin-specific protease inhibitorsVALO HEALTH INC·Filed 2020·Granted May 10, 2022·0 cites·20 claims
- 3657US12252490B2Inhibiting deubiquitinase USP25 and USP28VALO HEALTH INC·Filed 2019·Granted Mar 18, 2025·0 cites·15 claims
- 3755US2015133450A1Methods and compositions useful for treating diseases involving bcl-2 family proteins with quinoline derivativesEUTROPICS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3852US2022087983A1Activating pyruvate kinase rFORMA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3949US10413549B2Methods and compositions useful for treating diseases involving Bcl-2 family proteins with isoquinoline and quinoline derivativesEUTROPICS PHARMACEUTICALS INC·Filed 2017·Granted Sep 17, 2019·0 cites·7 claims
- 4049US2016038503A1Methods and compositions useful for treating diseases involving bcl-2 family proteins with isoquinoline and quinoline derivativesRICHARD DAVID·Filed 2013·Application pending·0 cites
- 4148US2008234262A1Pyrazolopyrimidine analogs and their use as mtor kinase and pi3 kinase inhibitorsWYETH CORP·Filed 2008·Application pending·0 cites
- 4229US8835429B2Pyrimidine compounds, their use as mTOR kinase and Pl3 kinase inhibitors, and their synthesesCURRAN KEVIN JOSEPH·Filed 2010·Granted Sep 16, 2014·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when David Richard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →